Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

35.30p
   
  • Change Today:
      2.30p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 1,320,816
  • Market Cap: £127.60m

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Christopher Paul Hancock 4,802,352 £1,695,230
Richard John Rees 2,805,902 £990,483
Craig Jonathan Gulliford 1,630,466 £575,554
John Bradshaw 1,371,082 £483,992
David Gerard Woods 440,255 £155,410
Charles Spicer 308,530 £108,911
Ivonne Cantu 125,000 £44,125

Major Shareholders

Notifier** Holding Value*
Canaccord Genuity Group Inc 39,303,064 £13,873,982
Development Bank of Wales plc 14,376,727 £5,074,985
Finance Wales 12,776,727 £4,510,185
Baillie Gifford & Co 12,537,441 £4,425,717
Creo Medical Group EBT 10,000,000 £3,530,000
M&G Investments 9,428,500 £3,328,260
The Capital Group Companies, Inc. 8,816,807 £3,112,333
AXA Framlington Investment Managers 7,992,961 £2,821,515
Hargreave Hale Limited 6,753,632 £2,384,032
Tellworth Investments 5,772,778 £2,037,791
Hoya Corporation 4,799,880 £1,694,358
Jonathan Craton 3,400,294 £1,200,304
Cotterford Co Limited 3,335,398 £1,177,396
Mark Farmer 3,121,607 £1,101,927
RBC Trustees (CI) Ltd 2,974,727 £1,050,079
Angel Co Fund 2,967,120 £1,047,393

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 35.30p
Change Today 2.30p
% Change 6.97 %
52 Week High 48.10
52 Week Low 23.25
Volume 1,320,816
Shares Issued 361.48m
Market Cap £127.60m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.08% below the market average15.08% below the market average15.08% below the market average15.08% below the market average15.08% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
13.95% above the market average13.95% above the market average13.95% above the market average13.95% above the market average13.95% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Income Not Available
Growth
15.86% below the market average15.86% below the market average15.86% below the market average15.86% below the market average15.86% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 17-May-2024

Time Volume / Share Price
17:07 37,500 @ 35.30p
16:35 305 @ 35.30p
16:35 305 @ 35.30p
16:28 29 @ 35.33p
16:20 3,539 @ 35.74p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page